American company Eli Lilly has claimed that it has made two types of medicine from the blood of a patient who has recovered from Corona. Antibody-derived drugs are being tested on humans and have shown very positive signs. The company has also produced a third drug that will soon be subjected to human trials.
Researcher and Chief Scientific Officer Daniel Skowronski said the drug is expected to arrive by September if everything goes well. He informed that for the first time in the world antibody-drug has been developed. Scientists from Canada and China have been doing research for a long time. This drug, named LY-COV 555 and JS016, blocks the outer tip of the virus so that it cannot reach and damage the healthy cells of the body. This is the first drug through which the structure of the corona’s spike protein can be inactivated. The new drug is more effective than the anti-TB, anti-TB drug used in the treatment of Kovid. This drug is a class of ‘monoclonal antibodies’, it is used in the treatment of cancer, arthritis.
Here, scientists in South Korea have identified conditions that increase the risk of corona patients manifold. Even his life is lost. Researchers say that if diabetes, fever, low amount of oxygen in the body, and heart injury are monitored then patients can be saved to a great extent. This study of researchers from the Medical Center University of Korea has been published in the Korean Medical Science Journal. Ahn Joon Hong, a professor and one of the researchers of the Department of Internal Medicine at the University, said that these findings would go a long way in identifying patients and treating them immediately.
The doctors researched 110 patients who came to the hospital, most of them elderly. Scientists found that the condition of 23 patients who had complaints like diabetes, fever, low oxygen in the body, and heart problems continued to worsen. They can be cured if treated immediately.